Skip to main content

Spectrum: Autism Research News

topic /

Treatments

Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.

January 2012

Funding fears prevent researchers from sharing their mice

by  /  9 January 2012

Despite funders’ requirements to share mouse models after publication, many researchers hoard the animals for the good of their labs — and that could have an adverse effect on the field as a whole.

Comments

Molecular mechanisms: Alzheimer’s protein linked to fragile X

by  /  4 January 2012

Lowering the levels of a protein associated with Alzheimer’s disease can rescue symptoms of fragile X syndrome in mice, according to a study published 26 October in PLoS One.

Comments

Research evolution

by  /  3 January 2012

A new study examining trends in autism research over the past 40 years found that the largest areas of growth have been in immune function, oxidative stress, toxin exposure, genetics and neuroimaging, while research on theory of mind and neuropathology has slowed.

Comments
December 2011

Adult decisions

by  /  20 December 2011

A new report outlines priorities for studying adults with autism, ranging from designing diagnostic tests to the most effective models of long-term care.

Comments

New scheme ramps up efforts to aggregate autism data

by  /  19 December 2011

The nation’s largest database of autism research is about to get even bigger, thanks to a partnership between the National Database for Autism Research, a repository of data from 25,000 participants, and the Autism Genetic Research Exchange, a database of 2,500 families.

Comments

Molecular mechanisms: Master regulator altered in autism

by  /  16 December 2011

SP1, a protein that regulates the expression of several autism candidate genes, could increase risk of the disorder by simultaneously altering the expression of a number of the genes, according to a study published 24 October in Biological Psychiatry.

Comments

Pharma’s shift

by  /  13 December 2011

Swiss drugmaker Novartis plans to close its neuroscience research facility in Switzerland, but research on fragile X drugs will continue.

Comments

Neurons made from stem cells reveal cellular flaws in autism

by  /  8 December 2011

Researchers have uncovered cellular abnormalities in Timothy syndrome by regenerating neurons from individuals with the rare autism-related disorder, according to a study published 27 November in Nature Medicine.

Comments

New system screens for drugs that alter neuronal junctions

by  /  7 December 2011

A new technique efficiently screens for compounds that enhance or inhibit the formation of synapses, the junctions between neurons, according to a study published 25 October in Nature Communications.

Comments

Small plates

by  /  6 December 2011

People with autism may be picky eaters because they are hesitant to try new things, but also because they may have an atypical sense of taste. 

Comments